Samuel U. Takvorian, MD, MS
Medical Oncology
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 2nd Floor West
View 1 additional location
Headshot of Samuel U. Takvorian, MD, MS
Penn Medicine Provider

About me

  • Assistant Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: Harvard Medical School
  • Residency: Mass General Brigham Healthcare Center - Chestnut Hill
  • Fellowship: University of Pennsylvania Health System

What my patients think about me

Average Rating

698 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

January 2026
i really like the way my provider takes time with and explains everything so the i understand. and we're both on the same page
January 2026
very cordial. great communication.
January 2026
very good doctor
January 2026
i do extensive homework regarding my illness and its treatment. dr. takvorian clearly strives to be knowledgeable of best science. he is clearly invested in what is best for his patient.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Takvorian is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Aleixo G, Ani J, Raghavendran K, Zuber C, Goldman N, Gabriel P, Singh A, Boisseau L, Takvorian S, Dougherty D, Dotan E, Sedhom R. Embedding Geriatric Oncology in a Community Practice of an Academic Health System: Implementation, Outcomes, and End-of-Life Impact , JCO Oncol Pract: 2026


Wainwright JV, Song W, Toneff H, Kalman J, Takvorian S, Rendle K. Effects of Integrating a Chatbot into Lung Cancer Care on Patient Medication Self Efficacy , American Society of Preventative Oncology: 2025


Abigail Pepin, Abigail Doucette, Neha Vapiwala, Vivek Narayan, Samuel Takvorian, Sophia O’Brien, David Mankoff, Philipose Mulugeta, Neil K. Taunk Safety of the Combination of External Beam Radiotherapy with 177Lu-PSMA-617 in Patients with Metastatic Castrate Resistant Prostate Cancer (mCRPC) , The Journal of Nuclear Medicine: 2025


Crawford TB, Tayeb M, Barrett E, Al-Saleem T, Kondam P, Hausler R, Symecko H, Orr C, Wolfe C, Mann D, Spielman K, Wong G, Haas N, Narayan V, Robinson K, Takvorian S, Wong YN, Sokolova A, Montgomery RB, Menendez C, Kelley MJ, Aiello LB, Garraway IP, Domchek SM, Maxwell KN. Pathogenic germline variants in a racially diverse real-world cohort of prostate cancer patients , medRxiv: 2025


Gabriel Aleixo, Julianne Ani, William J. Ferrell, Ravi Bharat Parikh, Peter Gabriel, Efrat Dotan, Simone Fernandes dos Santos Hughes, Ramy Sedhom, Samuel U. Takvorian Practical geriatric assessment (PGA) implementation strategies and correlative evaluations (PACE-70): A hybrid implementation-effectiveness study in 3 community practices. , 2025 ASCO Annual Meeting, Chicago, IL: 2025


Gabriel Aleixo, Tej Patel, Julianne Ani, Will J. Ferrell, Efrat Dotan, Samuel U. Takvorian, Grant R. Williams, Ravi B. Parikh, Ramy Sedhom “Start low, go slow,” a strategy to tailor treatment dosing in older or vulnerable adults with advanced solid cancer: A systematic review and meta-analysis , Journal of Geriatric Oncology: 2025


Seiichi Villalona, Carlos Chavez Perez, E. Paul Wileyto, Samuel Takvorian, Peter Gabriel, Abigail Doucette, Daniel Blumenthal, Robert Schnoll Predictive Value of Individual Behavioral Risk Factors for New Mood-Related Psychiatric Disorder After Diagnosis of Cancer , Psycho-Oncology: 2024


Schnoll R, Bekelman JE, Blumenthal D, Asch DA, Buttenheim AM, Chaiyachati KH, Domchek SM, Fayanju OM, Gabriel P, Jenssen BP, Leone FT, McCarthy AM, Nathanson KL, Parikh RB, Rendle KA, Shelton RC, Shulman LN, Takvorian SU, Ware S, Wileyto EP, & Beidas RS Using the Translational Science Benefits Model to assess the impact of the Penn Implementation Science Center in Cancer Control , Journal of Clinical and Translational Science, 8(1): 2024


J. Wainwright, H. Toneff, J. Kalman, M. Mengesha, A. Strazinsky, W. Song, S. Beucker, E.P. Wileyto, C. Johnston, C. Cambareri, D. Yarosh, A. Blauch, D. Pucci, L.A. Jacobs, J.E. Bekelman, S.E. Kimmel, L.N. Shulman, S. Takvorian, K. Rendle Acceptability and Feasibility of Integrating A Chatbot into Routine Lung Cancer Care: Patient and Clinician Perspectives , Journal of Thoracic Oncology, International Association for the Study of Lung Cancer, 19(10): 2024


Montgomery A, White J, Blumenthal D, Mengesha M, O’Brien C, Ragusano D, Beidas RS, Schnoll R, Bekelman JE, Parikh RB, Takvorian SU, & Rendle KA Patient and clinician perspectives on the timing of serious illness conversations in oncology , ASCO Quality Care Symposium, San Francisco, CA: 2024


View all publications